Tag: clinical trials

Digital Roadmaps and Business Cases to Justify Investment in Cybersecurity & Identity/Access Management

Posted on By digi

Digital Roadmaps and Business Cases to Justify Investment in Cybersecurity & Identity/Access Management Digital Roadmaps and Business Cases to Justify Investment in Cybersecurity & Identity/Access Management As clinical trials evolve in complexity and scope, the need for robust cybersecurity and effective identity/access management becomes paramount. With an increase in the amount of sensitive patient data…

Read More “Digital Roadmaps and Business Cases to Justify Investment in Cybersecurity & Identity/Access Management” »

Cybersecurity & Identity/Access Management

KRIs, KPIs and Dashboards to Monitor Cybersecurity & Identity/Access Management Performance

Posted on By digi

KRIs, KPIs and Dashboards to Monitor Cybersecurity & Identity/Access Management Performance KRIs, KPIs and Dashboards to Monitor Cybersecurity & Identity/Access Management Performance In the rapidly evolving landscape of clinical research, particularly concerning outsourcing in clinical trials, the importance of effective cybersecurity and identity/access management cannot be overstated. Clinical trials, especially those developing new pharmaceuticals or…

Read More “KRIs, KPIs and Dashboards to Monitor Cybersecurity & Identity/Access Management Performance” »

Cybersecurity & Identity/Access Management

Inspection-Ready Documentation Standards for Communication with IRB/Regulators

Posted on By digi

Inspection-Ready Documentation Standards for Communication with IRB/Regulators Inspection-Ready Documentation Standards for Communication with IRB/Regulators Introduction Effective communication with Institutional Review Boards (IRB) and regulatory authorities is critical in the landscape of clinical trials, particularly when it concerns the standards for documentation. The nuances of these communications vary depending on the geographic region, including the US,…

Read More “Inspection-Ready Documentation Standards for Communication with IRB/Regulators” »

Communication with IRB/Regulators

KRIs, KPIs and Dashboards to Monitor Communication with IRB/Regulators Across Portfolios

Posted on By digi

KRIs, KPIs and Dashboards to Monitor Communication with IRB/Regulators Across Portfolios KRIs, KPIs and Dashboards to Monitor Communication with IRB/Regulators Across Portfolios Introduction to Key Risk Indicators (KRIs), Key Performance Indicators (KPIs), and Dashboards In clinical research, effectively monitoring communication with Institutional Review Boards (IRBs) and regulatory authorities is critical. This monitoring ensures compliance with…

Read More “KRIs, KPIs and Dashboards to Monitor Communication with IRB/Regulators Across Portfolios” »

Communication with IRB/Regulators

Case Studies: Communication with IRB/Regulators That Strengthened Safety Oversight

Posted on By digi

Case Studies: Communication with IRB/Regulators That Strengthened Safety Oversight Effective communication with Institutional Review Boards (IRBs) and regulatory agencies is essential for ensuring patient safety and regulatory compliance in clinical trials. As professionals in clinical operations, regulatory affairs, and medical affairs, understanding how to navigate these communications can significantly influence the efficacy of trial oversight….

Read More “Case Studies: Communication with IRB/Regulators That Strengthened Safety Oversight” »

Communication with IRB/Regulators

Aligning Cybersecurity & Identity/Access Management With GCP, Privacy and Regulatory Expectations

Posted on By digi

Aligning Cybersecurity & Identity/Access Management With GCP, Privacy and Regulatory Expectations Aligning Cybersecurity & Identity/Access Management With GCP, Privacy and Regulatory Expectations The alignment of cybersecurity and identity/access management with Good Clinical Practice (GCP) and regulatory expectations is essential for clinical trials, including schizophrenia clinical trials. This alignment is crucial not only for safeguarding sensitive…

Read More “Aligning Cybersecurity & Identity/Access Management With GCP, Privacy and Regulatory Expectations” »

Cybersecurity & Identity/Access Management

Architecture and Integration Approaches for Enterprise-Grade Cybersecurity & Identity/Access Management

Posted on By digi

Architecture and Integration Approaches for Enterprise-Grade Cybersecurity & Identity/Access Management Architecture and Integration Approaches for Enterprise-Grade Cybersecurity & Identity/Access Management Cybersecurity and Identity/Access Management (IAM) are critical components in ensuring compliance and protecting sensitive data in clinical trials. This step-by-step tutorial provides extensive guidance for clinical operations, regulatory affairs, and medical affairs professionals in the…

Read More “Architecture and Integration Approaches for Enterprise-Grade Cybersecurity & Identity/Access Management” »

Cybersecurity & Identity/Access Management

Common Pitfalls in Communication with IRB/Regulators—and How to Avoid Regulatory Findings

Posted on By digi

Common Pitfalls in Communication with IRB/Regulators—and How to Avoid Regulatory Findings Effective communication with Institutional Review Boards (IRBs) and regulatory agencies is critical for the successful conduct of clinical research trials. Navigating the regulatory landscape can be challenging, particularly given the complexities and nuances involved in obtaining approvals, reporting changes, and maintaining compliance with evolving…

Read More “Common Pitfalls in Communication with IRB/Regulators—and How to Avoid Regulatory Findings” »

Communication with IRB/Regulators

Aligning Communication with IRB/Regulators With GCP, ICH E2A–E2F and Local Regulations

Posted on By digi

Aligning Communication with IRB/Regulators With GCP, ICH E2A–E2F and Local Regulations In the domain of translational clinical research, effective communication with Institutional Review Boards (IRBs) and regulators is critical for the success of clinical trial operations. This article serves as a comprehensive guide, structured step-by-step, to navigate the complexities of aligning communication with regulatory bodies…

Read More “Aligning Communication with IRB/Regulators With GCP, ICH E2A–E2F and Local Regulations” »

Communication with IRB/Regulators

Digital Tools and Automation to Streamline Communication with IRB/Regulators

Posted on By digi

Digital Tools and Automation to Streamline Communication with IRB/Regulators Digital Tools and Automation to Streamline Communication with IRB/Regulators The landscape of clinical trials is evolving rapidly, particularly in the domains of communication with Institutional Review Boards (IRBs) and regulatory authorities. As organizations like Amgen advance their clinical trials, including the integration of real-world evidence (RWE)…

Read More “Digital Tools and Automation to Streamline Communication with IRB/Regulators” »

Communication with IRB/Regulators